Use of adjuvant chemotherapy in resected non-small cell lung cancer in real-life practice: a systematic review of literature

BACKGROUND: Adjuvant chemotherapy (AC) is recommended since 2004 for patients with a completely resected non-small cell lung cancer (NSCLC). Indeed, several randomized clinical trials have demonstrated an improved survival for patients treated with adjuvant cisplatin-based regimen than surgery alone...

Descripción completa

Detalles Bibliográficos
Autores principales: Desage, Anne-Laure, Bouleftour, Wafa, Tiffet, Olivier, Fournel, Pierre, Tissot, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743521/
https://www.ncbi.nlm.nih.gov/pubmed/35070767
http://dx.doi.org/10.21037/tlcr-21-557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743521/
https://www.ncbi.nlm.nih.gov/pubmed/35070767
http://dx.doi.org/10.21037/tlcr-21-557

Ejemplares similares